P17

The most effective method in treatment of inoperable cancer is currently miniallogeneic transplantation. This type of treatment focuses on reaction of “graft-versus-tumor”. According to preliminary data, such treatment leads to long-term remission in patients with metastatic cancer, who did not respond to previous therapy. Anti-tumor immune response after transplant may be extended or enhanced by additional infusion of donor lymphocytes. Research has shown that introduction of donor lymphocytes achieves complete remission of the tumor, even in case of relapse after allogeneic transplantation from the same donor, but these effects are unstable and not so long because of rapid elimination of donor lymphocytes [1] . The main problem is the preservation of cell transplantation viability and functional activity of the cells in patient’s body, and protecting them from recipient’s immune system. In recent years, most suitable for this purpose are the three-dimensional porous biomaterials (3D-scaffold). Specific pore space does not allow immunity effectors quickly destroy the cells in scaffold [2,3] . Research Institute of medical materials and implants with shape memory at the Tomsk State University created a porous-permeable incubators (scaffold) of TiNi-based shape memory alloy (TiNi). The material has unique properties: permeable porous structure by open interconnected pores, characterized by high degree of wettability with tissue media and nanoporous inner surface of the pore walls, exhibits high adhesion to various cell types, so all mentioned meet requirements of the bio-chemical and bio-mechanical compatibility. Porous TiNi-based scaffolds allow continually to keep the functionality cells and prolong their action [4,5]. The purpose of this study was to investigate possibility of modulation of antitumor response in allogeneic bone marrow transplantation in porous-permeable incubator of TiNi. Results Intraperitoneal injection of allogeneic bone marrow (BM) reduces metastasis by 30% and has easy 10%-antitumor effect. At the same time, the implantation of bone marrow cells on incubator of TiNi (BM + TiNi) leads to more pronounced antitumor (25%) and significant antimetastatic effects (45%). Life span of animals with tumors and implanted bone marrow cells on incubator TiNi is increased by 60% Since bone marrow cells do not have direct antiproliferative effect on tumor target cells in vitro, it is assumed that one of the mechanisms effecting the bone marrow tran